The short answer: anywhere from about $30 for a research vial to $445 a month at a clinic, and the price tracks the route, not the molecule.
What you're really choosing between isn't a cheap BPC-157 and an expensive one. It's four different channels with four different legal positions. One of them sells you a supervised program. One sells you a supplement bottle. One sells you a vial labeled "not for human use." None of them sells you an FDA-approved drug, because there isn't one.
Here's what each route lists, where those numbers come from, and what the law says about each.
Status as of October 21, 2026: BPC-157 is not FDA-approved for any use. FDA removed it from its "do not compound" Category 2 list in April, but it is not on the list of substances pharmacies may compound from. An FDA advisory panel voted 8-6 in July to recommend adding it. A reported HHS "interim access" policy that may cover it is under White House review and has not been published. Nothing here is medical advice or a recommendation to use any route.
Where I get mine: the vendors I use, and how I vetted them.
How much does BPC-157 cost by route?
Here are the published numbers I could verify, with the legal status of each route next to them.
Route | Typical listed price | Legal status | Source |
|---|---|---|---|
In-person clinic program (compounded injectable) | $445 per one-month cycle; $307.50 a month on a 6-cycle plan | Not FDA-approved. Not on the list of substances pharmacies may compound from | |
Clinic, per vial | $195 a vial; $595 for a 2-month program with one vial, a follow-up and labs | Same as above | |
Telehealth programs | $199 to $425 a month | Same as above | A clinic's own market breakdown (Perfect B) |
Oral capsules sold as supplements | Varies; listed only by sellers | DoD's supplement-safety program says BPC-157 "is not a dietary ingredient" | Status from OPSS, Sept 2025 |
Research vials ("research use only") | About $30 to $100 a vial | Sold as not for human use. FDA has said that label doesn't hold when the evidence points to human use | Clinic summaries (Perfect B; Southern Care, Hattiesburg, MS) |
A few caveats on that table:
These are listings, not market data. Clinic prices come from clinics' own pages. Nobody has surveyed what people actually pay.
The vial range comes from clinics describing their competition. I'm not naming vendors in this table, and clinics have a reason to make the cheap route look risky.
Dates drift. Perfect B's page was updated October 13, 2026, but says its pricing is "current as of May 2026." The directory listing calls its numbers "directional."
How much does BPC-157 cost per month?
At a clinic, the published monthly numbers I found run from about $199 to $445, before extras.
Perfect B, a clinic in Doral, Florida, lists $445 per cycle and says "most cycles run about one month." Buy six cycles up front and it drops to $1,845, or $307.50 a month. Every plan starts with a $150 consultation deposit that's credited toward treatment (Perfect B).
Higher figures float around too. TheStreet quoted a Florida healthcare marketer, whose business is paid by clinics, giving "a range of $500 to $1,500 per month" as "a local reference point" (TheStreet via AOL, Oct 10, 2026). That's one person's estimate, not a survey.
The things that push a monthly bill up:
The first month. Consults and baseline labs are often billed up front.
Labs. Some programs include them, some charge separately.
Prepaid packages. Cheaper per month, but you're paying for months under a legal status that could change halfway through. TheStreet made the same point.
How much does a cycle of BPC-157 cost?
There's no standard "cycle." It's whatever the seller defines it as.
The one clinic that publishes a definition says a cycle is about a month and costs $445 (Perfect B). Another listing sells a two-month program for $595 (HealingMaps). Research vials are priced per vial, and how many vials make a "cycle" depends on dosing, which I'm not getting into here. There are no human trials that established one.
How much do BPC-157 and TB-500 cost together?
It depends entirely on how the clinic counts the stack.
Perfect B lists a two-peptide stack at $795 per cycle. But it prices its BPC-157 plus TB-500 "Wolverine Stack" at the same $445 as BPC-157 alone, "because it counts as one peptide in our stack pricing" (Perfect B). TheStreet's write-up of the same clinic reported $795 for the BPC-157 and TB-500 stack (TheStreet via AOL), so ask for the number in writing.
Legally, TB-500 sits in exactly the same spot as BPC-157: off Category 2 since April, voted 8-6 with one abstention in July, not yet on the compounding list (Holland & Knight, Oct 16, 2026). How the two compare on the evidence is in BPC-157 vs TB-500.
Can a pharmacy legally compound BPC-157 right now?
Not under FDA's current lists. That's the part most price pages skip.
Here's the sequence:
2023. FDA put BPC-157 in Category 2, its list of bulk substances that raise significant safety concerns (Holland & Knight).
April 15, 2026. FDA announced it would remove 12 peptides, BPC-157 among them, from Category 2 because the nominators withdrew them. A compounding law firm wrote that "Removal from Category 2 does not render these bulk drug substances eligible for compounding under section 503A" (Frier Levitt, Apr 16, 2026). FDA's own nominations list, updated May 14, puts BPC-157 in neither Category 1 nor Category 2 (FDA).
July 23-24, 2026. FDA's own reviewers told the advisory committee the evidence "weigh[s] against" adding BPC-157 to the compounding list (FDA briefing document). The committee voted 8-6, with one abstention, to recommend it anyway. The vote is advisory. FDA still has to propose a rule and finalize it (Holland & Knight). The full vote breakdown is in the FDA panel vote post.
October 14, 2026. HHS sent an "Interim Access Policy for Compounding Using Certain Peptides" to the White House budget office for review (Holland & Knight). Two people familiar with it told the AP it "is intended to allow pharmacies to temporarily compound some of the most popular peptides, including BPC-157" (AP via NBC News, Oct 16, 2026).
That last one is enforcement discretion, not approval. It would mean FDA declines to go after certain pharmacies. It wouldn't make BPC-157 an approved drug, and it could be withdrawn without formal rulemaking (Holland & Knight). As of today the text isn't public, so nobody outside government knows which peptides it covers or what conditions come with it.
So when a clinic page says its price includes "the compounded medication," that's a description of what they sell, not a sign the route is settled. You'll see vendor blogs claiming BPC-157 was "reclassified" back in February. FDA's documents don't show that. Every step is tracked on the compounding status tracker.
Are BPC-157 capsules legal to sell as a supplement?
Not according to the regulators who've weighed in.
The Defense Department's Operation Supplement Safety program says: "Despite being marketed in some health and wellness products, BPC-157 is not a dietary ingredient. It is an unapproved drug and prohibited peptide with unknown safety profile" (OPSS, Sept 2025). FDA's July briefing notes, as a plain fact, that "BPC-157 is marketed in the United States as an ingredient in dietary supplement products formulated as oral capsules and tablets" (FDA briefing).
Two more things worth knowing before you compare capsule prices to anything else:
There's no human data on the oral route for the uses it was nominated for. FDA's reviewers wrote that they "did not identify any studies that administered BPC-157 via the oral, SC, nasal, or transdermal" route in people with ulcerative colitis (FDA briefing).
The interim policy wouldn't help here. Holland & Knight says any interim approach under discussion wouldn't cover supplement channels.
Athletes have one more problem: BPC-157 is on WADA's prohibited list under S0, non-approved substances (USADA).
Why are research vials so much cheaper?
Because you're buying the powder and none of the oversight, and the label says it isn't for you.
A clinic in Florida put it directly: "When you buy BPC-157 for $49 from a research peptide vendor versus $445 from a medical clinic," the difference is the supervision and the pharmacy chain (Perfect B). That's a clinic arguing its own case. But the gap is real.
What the low price doesn't cover:
Legal cover. FDA's August 24 warning letters to online peptide sellers said "research use only" labels "did not outweigh evidence that the products were intended for human use" (Holland & Knight). More on that in what RUO actually means and what FDA told five vendors.
Any future policy. The interim policy, as reported, wouldn't extend to research-chemical sellers.
Knowing what's in the vial. If you're reading a vial's paperwork, how to read a COA covers what it does and doesn't prove.
Does insurance cover BPC-157?
No. There's nothing for an insurer to cover.
FDA's reviewers note that BPC-157 is not "a component of an FDA-approved drug," and that there are no approved products containing it in any country they searched (FDA briefing). With no approved product, there's nothing to put on a formulary. Clinics say the same thing from the other side: Perfect B's page states "Insurance does not cover BPC-157," including PPO, HMO, Medicare and Medicaid, and says HSA or FSA eligibility "depends on the individual plan administrator" (Perfect B).
Does a prescription change the cost?
A prescription changes the channel, not who pays. A BPC-157 prescription gets you a clinic or telehealth program at the prices above, paid out of pocket. It doesn't make the drug approved, and it doesn't make the compounding question go away. That's still waiting on FDA.
What would change the price?
The interim policy is the thing to watch. If it's published and covers BPC-157, more pharmacies might be willing to make it, and more compounders would likely mean more competition on price. That's a guess about markets, not a forecast. If it stalls or comes out narrow, nothing changes. The tracker gets updated when the paperwork moves.
Next step: see the vendors I use and how they score on testing, reviews and support. Code BHN40 takes 40% off.
If you've paid for BPC-157 through any of these routes, reply and tell me what you paid, what it included, and whether anyone told you about the legal status before you paid. Price pages are written by sellers. You're the better source.